{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:56:04Z","timestamp":1791831364750,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jvascsurg.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jvs.2017.07.065","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T17:15:24Z","timestamp":1507914924000},"page":"1576-1586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Review of aspirin and clopidogrel resistance in peripheral arterial disease"],"prefix":"10.1016","volume":"66","author":[{"given":"Mina","family":"Guirgis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2017.07.065_bib1","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/ejh.12406","article-title":"The clinical utility of Multiplate analyser measurement in platelet function testing following stroke and transient ischaemic attack","volume":"94","author":"Mannu","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jvs.2017.07.065_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jth.12538","article-title":"Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis","volume":"12","author":"Wisman","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvs.2017.07.065_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4065\/81.4.518","article-title":"Aspirin and clopidogrel resistance","volume":"81","author":"Michos","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jvs.2017.07.065_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2012.04639.x","article-title":"Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study","volume":"10","author":"Siller-Matula","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvs.2017.07.065_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.amjcard.2009.04.015","article-title":"Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis","volume":"104","author":"Pinto Slottow","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A\u00a0prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib8","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"Geisler","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2017.07.065_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2017.07.065_bib10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00228-015-1917-9","article-title":"Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study","volume":"71","author":"Collet","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jvs.2017.07.065_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.2005.00419.x","article-title":"Aspirin resistance in secondary stroke prevention","volume":"113","author":"Berrouschot","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jvs.2017.07.065_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ahj.2006.10.040","article-title":"Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review","volume":"153","author":"Hovens","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2017.07.065_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","article-title":"Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis","volume":"154","author":"Snoep","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2017.07.065_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/09537104.2012.676220","article-title":"Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease","volume":"24","author":"Mazur","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.jvs.2017.07.065_bib15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1055\/s-0038-1657677","article-title":"Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty","volume":"78","author":"Mueller","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2017.07.065_bib16","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jvs.2009.06.023","article-title":"Current evidence and clinical implications of aspirin resistance","volume":"50","author":"Kasotakis","year":"2009","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.07.065_bib17","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2013.03.036","article-title":"Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity","volume":"61","author":"Spiliopoulos","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00270-013-0558-6","article-title":"Periprocedural prophylactic antithrombotic strategies in interventional radiology: current practice in the Netherlands and comparison with the United Kingdom","volume":"36","author":"Wiersema","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejvs.2016.04.023","article-title":"Lack of evidence for dual antiplatelet therapy after endovascular arterial procedures: a meta-analysis","volume":"52","author":"Peeters Weem","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2017.07.065_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jvs.2015.01.051","article-title":"Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease","volume":"62","author":"Armstrong","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.07.065_bib21","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1111\/j.1538-7836.2005.01640.x","article-title":"Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial","volume":"3","author":"Eikelboom","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvs.2017.07.065_bib22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1160\/TH12-10-0758","article-title":"High on-treatment platelet reactivity\u2014definition and measurement","volume":"109","author":"Cattaneo","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2017.07.065_bib23","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/S0002-8703(98)70245-5","article-title":"Assessment of platelet function assays","volume":"135","author":"Nicholson","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2017.07.065_bib24","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A\u00a0comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","volume":"28","author":"Lordkipanidze","year":"2007","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.jvs.2017.07.065_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2298\/SARH10S1059S","article-title":"Platelet function tests and resistance to antiplatelet therapy","volume":"138","author":"Stegnar","year":"2010","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.jvs.2017.07.065_bib26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/clc.22031","article-title":"Aspirin resistance: current status and role of tailored therapy","volume":"35","author":"Grinstein","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.amjcard.2009.03.022","article-title":"Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy","volume":"104","author":"Ben-Dor","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib30","first-page":"1","article-title":"The prognostic utility of tests of platelet function for the detection of \u2018aspirin resistance\u2019 in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation","volume":"19","author":"Dretzke","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jvs.2017.07.065_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/0953710021000057866","article-title":"Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients","volume":"13","author":"Ziegler","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.jvs.2017.07.065_bib32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1445-2197.2006.03693.x","article-title":"Point of care testing of aspirin resistance in patients with vascular disease","volume":"76","author":"Wong","year":"2006","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jvs.2017.07.065_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/09537104.2011.577254","article-title":"Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis","volume":"22","author":"Madsen","year":"2011","journal-title":"Platelets"},{"key":"10.1016\/j.jvs.2017.07.065_bib34","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jvs.2010.08.029","article-title":"Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients","volume":"53","author":"Saunders","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.07.065_bib35","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jvs.2007.01.064","article-title":"Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: flow cytometric measurement of aspirin-induced platelet inhibition","volume":"45","author":"Assadian","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.07.065_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5603\/KP.a2014.0237","article-title":"Evaluation of aspirin resistance and the presence of unstable carotid plaque in patients undergoing carotid endarterectomy","volume":"73","author":"Lewszuk","year":"2015","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jvs.2017.07.065_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1755-5922.2010.00259.x","article-title":"Microembolic signals and aspirin resistance in patients with carotid stenosis","volume":"30","author":"Dawson","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jvs.2017.07.065_bib38","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00277-009-0708-8","article-title":"Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up","volume":"88","author":"Linnemann","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jvs.2017.07.065_bib39","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1160\/TH05-12-0808","article-title":"Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease","volume":"95","author":"Wong","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2017.07.065_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1160\/TH03-12-0758","article-title":"Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance?","volume":"92","author":"Payne","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2017.07.065_bib41","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2017.07.065_bib42","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1517\/14656566.2014.953054","article-title":"Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures","volume":"15","author":"Spiliopoulos","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jvs.2017.07.065_bib43","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0140-6736(10)61274-3","article-title":"Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2017.07.065_bib44","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jvs.2014.03.293","article-title":"Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease","volume":"60","author":"Guo","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2017.07.065_bib45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jacc.2009.12.071","article-title":"Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis","volume":"56","author":"Hulot","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1024\/0301-1526\/a000510","article-title":"High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease","volume":"45","author":"Bernlochner","year":"2016","journal-title":"Vasa"},{"key":"10.1016\/j.jvs.2017.07.065_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejvs.2015.09.020","article-title":"Effect of CYP2C19 polymorphisms on the platelet response to clopidogrel and influence on the effect of high versus standard dose clopidogrel in carotid artery stenting","volume":"51","author":"Gonzalez","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2017.07.065_bib48","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.06.024","article-title":"Clopidogrel resistance after minor ischemic stroke or transient ischemic attack is associated with radiological cerebral small-vessel disease","volume":"24","author":"Lundstrom","year":"2015","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jvs.2017.07.065_bib49","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.7754\/Clin.Lab.2013.131007","article-title":"Response to dual antiplatelet therapy in patients with peripheral artery occlusive disease suffering from critical limb ischemia","volume":"60","author":"Wand","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.jvs.2017.07.065_bib50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3349\/ymj.2013.54.2.288","article-title":"The influence of anti-platelet resistance on the development of cerebral ischemic lesion after carotid artery stenting","volume":"54","author":"Song","year":"2013","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jvs.2017.07.065_bib51","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00270-013-0577-3","article-title":"Clopidogrel responsiveness in patients undergoing peripheral angioplasty","volume":"36","author":"Pastromas","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib52","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy\u2014the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib53","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.113.002589","article-title":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial","volume":"128","author":"Steg","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2017.07.065_bib54","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2017.07.065_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2017.07.065_bib56","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521417317858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521417317858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T18:30:56Z","timestamp":1572719456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521417317858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0741521417317858"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2017.07.065","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of aspirin and clopidogrel resistance in peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2017.07.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}